Thermo Fisher Scientific is here to help you accelerate the pace of gene therapy development. We offer high-quality solutions, regulatory documentation and support, and access to expert consultation—allowing for a seamless transition from basic research to the clinic and commercialization.

To learn more about how we can help, read our article, “Upstream and downstream solutions for AAV manufacturing”. In this article, we discuss current AAV manufacturing workflows and identify areas for process improvement, at both upstream and downstream points, that support increasing demands for scalable manufacture of viral vectors.

To obtain your copy, complete the form below:

(*Indicates a mandatory field)